Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
Go back to Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease| Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) | Delayed: 31.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.38 | 52 Week High | $3.00 | |||
| Open | $31.38 | 52 Week Low | $0.51 | |||
| Day High | $31.40 | P/E | N/A | |||
| Day Low | $31.36 | EPS | $-0.25 | |||
| Volume | 2,097,513 | |||||
